Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
type: MedicalStudy
description: Infusional FOLFOX Plus Camrelizumab and Apatinib Versus HAIC-FOLFOX Plus Camrelizumab and Apatinib for Hepatocellular Carcinoma of BCLC C Stage: A Multi-center Randomized Phase III Trial
status: RECRUITING
study design: INTERVENTIONAL
phase: PHASE3
start date: 2023-07-01
end date: 2029-07-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06172205
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
study subject: BCLC Stage C Hepatocellular Carcinoma
study subject: Chemotherapy Effect
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: RECRUITING
keywords: BCLC Stage C Hepatocellular Carcinoma
keywords: Chemotherapy Effect

AI Analytics
type: Organization